Airtime: ET
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.
Mad Money host Jim Cramer gives his take on the markets.
Dissecting the FOMC minutes, with James Bianco, Bianco Research; Zane Brown, Lorb Abbett and CNBC's Steve Liesman.
Discussing whether a new $487M investment from the government will help speed up the production of the most important vaccines, with Kathy Sebelius, Health & Human Services secretary and CNBC's Mike Huckman.